Multicountry study of SARS-CoV-2 and associated risk factors among healthcare workers in Côte d'Ivoire, Burkina Faso and South Africa

Author:

Kribi Sarah1,Touré Fidèle2,Mendes Adriano3,Sanou Soufiane4,Some Arsène4,Aminou Abdoul M2,Belarbi Essia1,Griessel Rosemary56,Hema Arsène7,Kabore Firmin4,Pitzinger Paul1,Strydom Amy3,Vietor Ann Christin1,Traoré Korotimi4,Zongo Arsène4,Anoh Etilé A2,Grossegesse Marica1,Hofmann Natalie1,Ouangraoua Soumeya4,Poda Armel7,Kagone Thérèse4,Schubert Grit1,Eckmanns Tim1,Venter Marietjie3,Leendertz Fabian1,Akoua-Koffi Chantal2,Tomczyk Sara1ORCID

Affiliation:

1. Robert Koch Institut P3 Seestraße 10 , Berlin 13353 , Germany

2. Centre Hospitalier Universitaire Bouaké, Laboratoire de Bactériologie et Virologie 01, 01 BP 1174 Bouaké, Bouaké , Côte d'Ivoire

3. Department of Medical Virology, University of Pretoria , Private Bag x 20 Hatfield 0028, South Africa

4. Le Centre Muraz, Ave Mamadou Konate, Bobo-Dioulasso , Burkina Faso

5. Department of Medical Microbiology, University of Pretoria , Private Bag x 20 Hatfield 0028, South Africa

6. Department of Medical Microbiology, Tshwane Academic Division, National Health Laboratory Service , Pretoria 0001, South Africa

7. Centre Hospitalier Sourô Sanou, Service d'épidemiologie , Ave Ponty, Bobo-Dioulasso, Burkina Faso

Abstract

Abstract Background Reports on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spread across Africa have varied, including among healthcare workers (HCWs). This study assessed the comparative SARS-CoV-2 burden and associated risk factors among HCWs in three African countries. Methods A multicentre study was conducted at regional healthcare facilities in Côte d’Ivoire (CIV), Burkina Faso (BF) and South Africa (SA) from February to May 2021. HCWs provided blood samples for SARS-CoV-2 serology and nasopharyngeal/oropharyngeal swabs for testing of acute infection by polymerase chain reaction and completed a questionnaire. Factors associated with seropositivity were assessed with logistic regression. Results Among 719 HCWs, SARS-CoV-2 seroprevalence was 34.6% (95% confidence interval 31.2 to 38.2), ranging from 19.2% in CIV to 45.7% in BF. A total of 20 of 523 (3.8%) were positive for acute SARS-CoV-2 infection. Female HCWs had higher odds of SARS-CoV-2 seropositivity compared with males, and nursing staff, allied health professionals, non-caregiver personnel and administration had higher odds compared with physicians. HCWs also reported infection prevention and control (IPC) gaps, including 38.7% and 29% having access to respirators and IPC training, respectively, in the last year. Conclusions This study was a unique comparative HCW SARS-CoV-2 investigation in Africa. Seroprevalence estimates varied, highlighting distinctive population/facility-level factors affecting COVID-19 burden and the importance of established IPC programmes to protect HCWs and patients.

Funder

Federal Ministry of Education and Research

Federal Ministry of Health, Germany

National Robert Koch Institute

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Medicine,Parasitology

Reference30 articles.

1. Outbreak brief 51: coronavirus disease 2019 (COVID-19) pandemic 2021;Africa CDC

2. COVID-19 in Africa: care and protection for frontline healthcare workers;Chersich;Glob Health,2020

3. WHO coronavirus (COVID-19) dashboard 2021;World Health Organization

4. COVID-19 in Germany and China: mitigation versus elimination strategy;Lu;Glob Health Action,2021

5. Keep health workers safe to keep patients safe;World Health Organization

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3